GlassScriptPhysician profile
Pourang Kamali
NPI 1609954171
$6,296.95
in general payments reported to CMS, 2019-2025
18 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,209 · 2020: $285 · 2021: $344 · 2022: $401 · 2023: $2,113 · 2024: $893 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,206 · Travel and Lodging: $336 · Gift: $304 · Education: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,205.59 |
| Travel and Lodging | $335.95 |
| Gift | $303.75 |
| Education | $212.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,327.29 | 2019-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $505.37 | 2024-2025 | Solyx Sis System, Bulkamid |
| Astellas Pharma US INC | $313.95 | 2022-2025 | Veozah |
| Abbvie INC. | $259.77 | 2019-2023 | |
| Pfizer INC. | $156.10 | 2019-2023 | |
| Hologic Sales and Service, LLC | $137.72 | 2022-2025 | Aptima, Novasure |
| Myovant Sciences INC. | $107.72 | 2021-2022 | |
| Roche Diagnostics Corporation | $100.15 | 2019-2021 | |
| Aspira Women'S Health INC | $86.99 | 2022-2024 | Ova1 |
| Baxter Healthcare | $63.82 | 2023 | Tisseel |
| Coopersurgical, INC. | $49.33 | 2019-2024 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $46.79 | 2025 | |
| Sumitomo Pharma America, INC. | $42.35 | 2024-2025 | Myfembree |
| Organon LLC | $31.51 | 2025 | |
| Millicent US INC | $19.96 | 2025 | Intrarosa, Femlyv |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.90 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.17 | 2020 | |
| Therapeuticsmd, INC. | $11.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pourang Kamali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.